|
Listeria-Based Therapeutic Cancer Vaccine for Melanoma
|
1R43CA153669-01A1
|
$200,763
|
$200,763
|
Brockstedt, Dirk
|
ADURO BIOTECH
|
|
Clinical trials data collection during patient care using a novel technology solu
|
1R43CA150466-01A1
|
$143,112
|
$57,245
|
Clary, Gregory
|
ADVANCED DIGITAL SYSTEMS, INC.
|
|
Bifunctional T cell receptor based immunotherapeutics
|
5R44CA097550-06
|
$990,016
|
$148,502
|
WONG, HING
|
ALTOR BIOSCIENCE CORPORATION
|
|
Community Clinical Oncology Program
|
2U10CA037422-23
|
$4,179,081
|
$41,791
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-22S2
|
$28,500
|
$285
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-22S3
|
$1,208,966
|
$12,090
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
American College of Radiology Imaging Network
|
5U01CA080098-12
|
$9,041,302
|
$452,065
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-21
|
$461,201
|
$4,612
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Repression by C SKI and Melanoma Progression
|
5R01CA084282-10
|
$264,568
|
$264,568
|
Donehower, Larry
|
BAYLOR COLLEGE OF MEDICINE
|
|
MOLECULAR DETERMINANTS OF BRAIN-METASTATIC MELANOMA
|
5R01CA086832-08
|
$279,192
|
$279,192
|
MARCHETTI, DARIO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
2P30CA125123-04
|
$3,089,219
|
$154,461
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S6
|
$100,000
|
$5,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-04S1
|
$250,400
|
$12,520
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of CD4+ T Cells in Antitumor Immunity
|
5R01CA090327-07
|
$309,164
|
$154,582
|
Wang, Rongfu
|
BAYLOR COLLEGE OF MEDICINE
|
|
Antigen specificity, suppressive mechanism & regulation of CD4+ regulatory T cell
|
5R01CA116408-05
|
$258,529
|
$258,529
|
Wang, Rongfu
|
BAYLOR COLLEGE OF MEDICINE
|
|
Improving the Efficacy of Dendritic Cell Vaccines
|
3P01CA084512-07S2
|
$200,000
|
$160,000
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Vaccination with IL-15 DC to Generate Melanoma-specific Protective Memory T Cells
|
1R01CA140602-01A2
|
$409,401
|
$409,401
|
PALUCKA, ANNA KAROLINA
|
BAYLOR RESEARCH INSTITUTE
|
|
Diversification of Cytotoxic Effector Cells Via LPS-activated DCs
|
5R01CA129350-03
|
$578,305
|
$578,305
|
PALUCKA, ANNA KAROLINA
|
BAYLOR RESEARCH INSTITUTE
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-26S1
|
$487,529
|
$4,875
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Spatial and Temporal Regulation of Angiogenesis
|
5P01CA092644-07
|
$1,307,514
|
$65,376
|
DVORAK, HAROLD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Rectifying defects in tumor vasculature to improve chemo- and radiation therapies
|
5R01CA129339-03
|
$352,750
|
$88,188
|
SENGER, DONALD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
|
5K08CA129204-03
|
$135,270
|
$67,635
|
ZEISBERG, ELISABETH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Orphan Nuclear Receptor TR3 in tumor angiogenesis and associated microvessel perm
|
5R01CA133235-02
|
$352,750
|
$352,750
|
ZENG, HUIYAN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
DEVELOPMENT OF A NANOSECOND PULSED ELECTRIC FIELD SYSTEM TO TREAT SKIN CANCER
|
2R44CA123924-02A1
|
$773,914
|
$773,914
|
NUCCITELLI, RICHARD
|
BIOELECTROMED CORPORATION
|
|
Applying nanosecond pulse electric fields to treat skin cancer
|
5R01CA125722-03
|
$409,354
|
$204,677
|
NUCCITELLI, RICHARD
|
BIOELECTROMED CORPORATION
|
|
The MB-CCOP at Boston Medical Center
|
1U10CA139519-01A1
|
$706,684
|
$14,134
|
KACHNIC, LISA
|
BOSTON MEDICAL CENTER
|
|
Cancer and Leukemia Group B CCOP Research Base
|
2U10CA037447-26
|
$2,316,114
|
$23,161
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Melanoma Stem Cells, Vasculogenesis and Neoplastic Progression
|
5R01CA138231-03
|
$343,699
|
$343,699
|
Frank, Markus
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cohort Study of Genetic Susceptibility to Cutaneous Malignant Melanoma
|
5R01CA122838-03
|
$360,695
|
$360,695
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
BMP7 in melanoma niche morphogenesis and homeostasis
|
1R01CA138649-01A2
|
$354,079
|
$354,079
|
HSU, MEI-YU
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SPORE in Skin Cancer
|
5P50CA093683-08
|
$2,300,000
|
$1,886,000
|
KUPPER, THOMAS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Variants in MicroRNA-Related Genes and Skin Cancer Risk
|
5R03CA139496-02
|
$89,000
|
$44,500
|
Nan, Hongmei
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Variants in Mitochondrial Genome and Skin Cancer Risk
|
5R03CA141606-02
|
$89,000
|
$22,250
|
Nan, Hongmei
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Population-Based Approach to Skin Cancer Epidemiology
|
5K07CA108978-05
|
$114,281
|
$114,281
|
QURESHI, ABRAR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Multifunctional nanoparticles for targeting aberrant tumorigenic pathways
|
1R01CA135242-01A2
|
$369,350
|
$121,886
|
Sengupta, Shiladitya
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Stem Cell-Engineered Tumor Immunity in Man
|
1P01CA132681-01A2
|
$3,043,786
|
$3,043,786
|
BALTIMORE, DAVID
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Nanosystems Biology Cancer Center 2
|
1U54CA151819-01
|
$2,586,441
|
$439,695
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Molecular Classification of Primary Cutaneous Melanoma
|
7R01CA122947-04
|
$320,530
|
$320,530
|
KASHANI-SABET, MOHAMMED
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
Microbial Exposures across the Lifespan and Cancer Risk in Women
|
1R21CA152839-01
|
|
$0
|
CLARKE, CHRISTINA
|
CANCER PREVENTION INSTIT OF CALIFORNIA
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-27
|
$821,099
|
$8,211
|
ROWLAND, KENDRITH
|
CARLE FOUNDATION
|
|
Novel device to study tumor metastasis in vitro
|
1R43CA141782-01A1
|
$150,362
|
$60,145
|
KHALDOYANIDI, SOPHIA
|
CASCADE LIFESCIENCES, INC.
|
|
Molecular studies of T cell clones for adoptive therapy
|
5K23CA109115-05
|
$134,460
|
$67,230
|
Kim, Julian
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cedar Rapids Oncology Project
|
5U10CA052352-21
|
$209,928
|
$2,099
|
WIESENFELD, MARTIN
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
New Thermal Sensitive Carboplatin Liposome for Cancer
|
1R43CA153694-01
|
$182,906
|
$182,906
|
Reed, Robert
|
CELSION CORPORATION
|
|
Semaphorin 3F: Structure, Function, and Anti-Metastatic Activity
|
5K01CA118732-05
|
$159,300
|
$79,650
|
BIELENBERG, DIANE
|
CHILDREN'S HOSPITAL BOSTON
|
|
ABCB5 P-Glycoprotein in Cancer Multidrug Resistance
|
5R01CA113796-05
|
$291,276
|
$291,276
|
Frank, Markus
|
CHILDREN'S HOSPITAL BOSTON
|
|
Cancer Biology in the Zebrafish
|
5R01CA103846-08
|
$372,487
|
$186,244
|
ZON, LEONARD
|
CHILDREN'S HOSPITAL BOSTON
|
|
Epigenetic Effect of the Microenvironment on Stem Cell Plasticity and Function
|
5R01CA121205-04
|
$330,969
|
$330,969
|
HENDRIX, MARY
|
CHILDREN'S MEMORIAL HOSPITAL (CHICAGO)
|
|
Endothelial Transdifferentiation of Invasive Tumor Cells
|
5R37CA059702-18
|
$393,942
|
$393,942
|
HENDRIX, MARY
|
CHILDREN'S MEMORIAL HOSPITAL (CHICAGO)
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-24
|
$1,202,700
|
$12,027
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
Total relevant funding to Melanoma for this search: $102,257,743
|